Table 2.
Anthropometric, cardiometabolic risk, and cardiorespiratory fitness data for participants who continued training (TRAIN) (n = 12) after the initial 13-week exercise training programme.
| Parameter | Post Program | +1 Week | +2 Weeks | +3 Weeks | +4 Weeks |
|---|---|---|---|---|---|
| Weight (kg) | 78.9 ± 7.3 | 78.6 ± 7.1 | 78.4 ± 7.5 | 78.3 ± 7.2 | 78.0 ± 7.2 |
| Waist circumference (cm) | 84.5± 3.6 | 84.4 ± 3.7 | 84.3 ± 3.7 | 84.3 ± 3.9 | 84.0 ± 3.7 |
| Body fat (%) | 27.1 ± 2.2 | ____ | 26.7 ± 2.4 | ____ | 26.3 ± 2.2 *,¥ |
| VO2max (mL·kg−1·min−1) | 34.2 ± 8.7 | ____ | 35.5 ± 8.3 * | ____ | 36.5 ± 8.0 *,¥ |
| Systolic BP (mmHg) | 117 ± 6 | 116 ± 6 | 116 ± 6 | 116 ± 6 | 115 ± 6 |
| Diastolic BP (mmHg) | 80 ± 7 | 79 ± 6 | 79 ± 5 | 79 ± 6 | 79 ± 5 |
| Total cholesterol (mg·dL−1) | 177 ± 25 | 176 ± 23 | 178 ± 23 | 178 ± 24 | 180 ± 25 |
| HDL cholesterol (mg·dL−1) | 61 ± 14 | 63 ± 13 | 63 ± 13 | 63 ± 13 | 63 ± 13 |
| LDL cholesterol (mg·dL−1) | 94 ± 18 | 93 ± 18 | 94 ± 19 | 93 ± 17 | 93 ± 17 |
| Triglycerides (mg·dL−1) | 97 ± 27 | 96 ± 22 | 95 ± 21 | 96 ± 21 | 95 ± 20 |
| Blood glucose (mg·dL−1) | 92 ± 11 | 92 ± 9 | 91 ± 9 | 91 ± 10 | 91 ± 10 |
| MetS z-score | −5.1 ± 1.9 | −5.3 ± 1.8 | −5.4 ± 1.8 | −5.4 ± 1.8 | −5.5 ± 1.8 |
Data displayed as mean ± SD, * p < 0.05 from post-program, ¥ p < 0.05 from +2 weeks. BP: blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; MetS: metabolic syndrome; VO2max: maximal oxygen consumption.